Europe Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Country

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Europe Hemostasis Diagnostics Market size values USD XX billion in 2022 and expected to reach USD XX billion in 2028 at a CAGR of X% from 2023-2029. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. Increase in the prevalence of hemostasis related disease in Europe countries (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), rise in number of surgery cases, rise in R&D investment for novel tests and devices innovation, and well developed healthcare infrastructure are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

Europe Hemostasis Diagnostics Market Dynamics

ncrease in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.

Key Features of the Reports

  • The europe hemostasis diagnostics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Europe Hemostasis Diagnostics Market Segmentation

By Product Type
  • Systems
  • Consumables
  • Point-of-Care Testing Devices
By Test Type
  • Fibrinogen Test
  • Activated Clotting Time
  • Platelet Function
  • Prothrombin Time
  • Heparin & Protamine Dose-Response Test For ACT
  • Activated Partial Thromboplastin Time
  • Anti-Factor Xa
  • Other Coagulation Tests
By Technology
  • Optical
  • Mechanical
  • Electrochemical
  • Others
By End User
  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others (POC)

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the countries market data: Germany, France, Italy, Spain, and United Kingdom (UK)

Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Alere Inc., Nihon Kohden Corporation

1.Executive Summary
2. Europe Hemostasis Diagnostics Market Introduction 
2.1. Europe Hemostasis Diagnostics Market  - Taxonomy
2.2. Europe Hemostasis Diagnostics Market  - Definitions
2.2.1.Product Type 
2.2.2.Test Type
2.2.3.Technology
2.2.4.End User
2.2.5.Country
3. Europe Hemostasis Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Europe Hemostasis Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Europe Hemostasis Diagnostics Market  By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Systems
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Consumables
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Point-of-Care Testing Devices
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Europe Hemostasis Diagnostics Market  By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Fibrinogen Test
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Activated Clotting Time
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Platelet Function
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Prothrombin Time
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Heparin & Protamine Dose-Response Test For ACT
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Activated Partial Thromboplastin Time
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Anti-Factor Xa
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Other Coagulation Tests
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7. Europe Hemostasis Diagnostics Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Optical
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Mechanical
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Electrochemical
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Europe Hemostasis Diagnostics Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinics
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic Centres
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others (POC)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Europe Hemostasis Diagnostics Market  By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Germany
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. France
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Italy
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. United Kingdom (UK)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Spain
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Rest of EU
9.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Germany Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Systems
10.1.2.Consumables
10.1.3.Point-of-Care Testing Devices
10.2.  Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Fibrinogen Test
10.2.2.Activated Clotting Time
10.2.3.Platelet Function
10.2.4.Prothrombin Time
10.2.5.Heparin & Protamine Dose-Response Test For ACT
10.2.6.Activated Partial Thromboplastin Time
10.2.7.Anti-Factor Xa
10.2.8.Other Coagulation Tests
10.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Optical
10.3.2.Mechanical
10.3.3.Electrochemical
10.3.4.Others
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Clinics
10.4.3.Diagnostic Centres
10.4.4.Others (POC)
11.France Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Systems
11.1.2.Consumables
11.1.3.Point-of-Care Testing Devices
11.2.  Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Fibrinogen Test
11.2.2.Activated Clotting Time
11.2.3.Platelet Function
11.2.4.Prothrombin Time
11.2.5.Heparin & Protamine Dose-Response Test For ACT
11.2.6.Activated Partial Thromboplastin Time
11.2.7.Anti-Factor Xa
11.2.8.Other Coagulation Tests
11.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Optical
11.3.2.Mechanical
11.3.3.Electrochemical
11.3.4.Others
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Clinics
11.4.3.Diagnostic Centres
11.4.4.Others (POC)
12.Italy Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Systems
12.1.2.Consumables
12.1.3.Point-of-Care Testing Devices
12.2.  Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Fibrinogen Test
12.2.2.Activated Clotting Time
12.2.3.Platelet Function
12.2.4.Prothrombin Time
12.2.5.Heparin & Protamine Dose-Response Test For ACT
12.2.6.Activated Partial Thromboplastin Time
12.2.7.Anti-Factor Xa
12.2.8.Other Coagulation Tests
12.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Optical
12.3.2.Mechanical
12.3.3.Electrochemical
12.3.4.Others
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Clinics
12.4.3.Diagnostic Centres
12.4.4.Others (POC)
13.United Kingdom (UK) Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Systems
13.1.2.Consumables
13.1.3.Point-of-Care Testing Devices
13.2.  Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Fibrinogen Test
13.2.2.Activated Clotting Time
13.2.3.Platelet Function
13.2.4.Prothrombin Time
13.2.5.Heparin & Protamine Dose-Response Test For ACT
13.2.6.Activated Partial Thromboplastin Time
13.2.7.Anti-Factor Xa
13.2.8.Other Coagulation Tests
13.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Optical
13.3.2.Mechanical
13.3.3.Electrochemical
13.3.4.Others
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Clinics
13.4.3.Diagnostic Centres
13.4.4.Others (POC)
14.Spain Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Systems
14.1.2.Consumables
14.1.3.Point-of-Care Testing Devices
14.2.  Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Fibrinogen Test
14.2.2.Activated Clotting Time
14.2.3.Platelet Function
14.2.4.Prothrombin Time
14.2.5.Heparin & Protamine Dose-Response Test For ACT
14.2.6.Activated Partial Thromboplastin Time
14.2.7.Anti-Factor Xa
14.2.8.Other Coagulation Tests
14.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Optical
14.3.2.Mechanical
14.3.3.Electrochemical
14.3.4.Others
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Clinics
14.4.3.Diagnostic Centres
14.4.4.Others (POC)
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Hoffmann-La Roche Ltd.
15.2.2.Sysmex Corporation
15.2.3.Abbott Laboratories
15.2.4.Alere Inc. 
15.2.5.Nihon Kohden Corporation
15.2.6.Siemens Healthineers
15.2.7.Danaher Corporation 
15.2.8.Instrumentation Laboratory
15.2.9.Grifols S.A
15.2.10.Beckman Coulter, Inc.
15.2.11.Emosis Diagnostics
16. Research Methodology 
17. Appendix and Abbreviations 
  • Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Abbott Laboratories
  • Alere Inc. 
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Danaher Corporation 
  • Instrumentation Laboratory
  • Grifols S.A
  • Beckman Coulter, Inc.
  • Emosis Diagnostics
  •